Ascendis Pharma A (ASND) Operating Leases (2018 - 2025)
Ascendis Pharma A (ASND) reported Operating Leases of $176.4 million for Q4 2025, up 77.42% on a YoY basis from $99.4 million in Q4 2024, and up 77.42% sequentially from $99.4 million in Q4 2024.
Ascendis Pharma A (ASND) Operating Leases (2018 - 2025) Analysis & Trends
Ascendis Pharma A (ASND) has 8 years of Operating Leases data on file, last reported at $176.4 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases rose 77.42% year-over-year to $176.4 million; the trailing twelve-month figure through Dec 2025 stood at $176.4 million (up 77.42% YoY), and the FY2025 full-year result was $176.4 million, up 75.17% from the prior year.
- Operating Leases grew to $176.4 million in Q4 2025, from $99.4 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $176.4 million in Q4 2025 to a low of $91.0 million in Q4 2023.
- A 5-year average of $112.9 million and a median of $108.0 million in 2021 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases soared 257.93% in 2021 and dropped 18.94% in 2022, its largest moves.
- Tracing ASND's Operating Leases over 5 years: stood at $120.1 million in 2021, then fell by 18.94% to $97.3 million in 2022, then slipped by 6.48% to $91.0 million in 2023, then grew by 9.21% to $99.4 million in 2024, then jumped by 77.42% to $176.4 million in 2025.
- Business Quant data shows ASND's Operating Leases at $176.4 million in Q4 2025, $99.4 million in Q4 2024, and $91.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 176.38 Mn |
| Dec 31, 2024 | 99.41 Mn |
| Dec 31, 2023 | 91.02 Mn |
| Sep 30, 2023 | 98.09 Mn |
| Dec 31, 2022 | 97.33 Mn |
| Dec 31, 2021 | 120.07 Mn |
| Sep 30, 2021 | 112.68 Mn |
| Jun 30, 2021 | 113.27 Mn |
| Mar 31, 2021 | 108.04 Mn |
| Dec 31, 2020 | 101.48 Mn |
| Sep 30, 2020 | 31.48 Mn |
| Jun 30, 2020 | 32.04 Mn |
| Mar 31, 2020 | 33.96 Mn |
| Dec 31, 2019 | 40.53 Mn |
| Sep 30, 2019 | 35.05 Mn |
| Jun 30, 2019 | 35.35 Mn |
| Mar 31, 2019 | 15.02 Mn |
| Dec 31, 2018 | 20.20 Mn |